Remove BioTech Remove Case Study Remove Life Science Remove Telemedicine
article thumbnail

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models.

BioTech 270
article thumbnail

Bonus Features – November 20, 2022 – 90% of healthcare buyers prioritize virtual care but want a clear roadmap, wearable data helped predict COVID-19 infections 12 days before the CDC, and more

Healthcare IT Today

A joint study by Omada Health, Rock Health, and the Digital Medicine Society, based on a survey of employers, payers and benefit consultants, found that 90% of purchasers view virtual care as a high priority , and the majority are willing to adopt innovative approaches, but few have a real understanding of what virtual care is.

eCare 52